Given Apple's strong performance in the last quarter, David Schechter, Sargon Portfolio, is currently revising model and could argue for a higher valuation.» Read More
Herbalife is reporting quarterly earnings after today's closing bell. Tim Ramey, D.A. Davidson senior research analyst, offers insight on the stock's performance in the last year.
Billionaire investor Carl Icahn spoke with CNBC's Scott Wapner on "Fast Money Halftime Report," about his stake in Herbalife. Wapner and CNBC's Herb Greenberg, share their opinions.
CNBC's Scott Wapner offers insight on his conversation with billionaire investor Carl Icahn regarding his stake in Herbalife. CNBC's Herb Greenberg, provides perspective.
Carl Icahn tells "Fast Money Halftime" that his primary motivation is to make money with his Herbalife bet, but he won't feel sorry if Bill Ackman's short position gets squeezed.
In a live telephone interview on “Fast Money Halftime,” Carl Icahn says his primary motive for betting on Herbalife is to make money, but he won’t feel sorry if Bill Ackman loses along the way. (2:07)
The FMHR traders share their opinions on Carl Icahn's massive Herbalife position. Icahn is expected to speak with CNBC's Scott Wapner ahead.
Billionaire investor Carl Icahn says he only buys stocks he believes are undervalued, like Herbalife. He says Ackman's paper on Herbalife contains no expert opinion and the exposure has given him a great opportunity to buy. The interview is followed by a discussion with the FMHR traders.
In a live “Fast Money Halftime” telephone interview, activist investor Carl Icahn is asked why he’s bought a stake in Herbalife, directly challenging Bill Ackman’s high-profile short against the company. (3:11)
CNBC's Herb Greenberg weighs in on Icahn's belief that Herbalife's business model is solid and his decision to take a 13 percent stake in the company.
Carl Icahn now has a 13 percent stake in Herbalife. How great will Icahn's Herbalife gain be compared to Bill Ackman's Herbalife pain? Or will the tables turn? CNBC's David Faber, Carl Quintanilla and Melissa Lee discuss.
Discussing Carl Icahn's stake in Herbalife, and how he might trade the stock, with Ken Squire, 13D Management founder.
Shares of the nutritional-supplement company are down 20% since the hedge-fund managers duked it out on CNBC on Jan 25.
The FMHR traders discuss the brawl heard around Wall Street over Herbalife.
What to make of the heated feud between Carl Icahn and hedge fund manager Bill Ackman over Herbalife, and whether there is money to be made in the world of finance anymore, with Barry Sternlicht, Starwood Capital Group.
People cannot stop talking about the "conversation" between hedge fund manager Bill Ackman and Carl Icahn Friday on CNBC. CNBC's Maria Bartiromo and Scott Wapner weigh in.
The "Squawk on the Street" news team report on today's market movers; including Carl Icahn upping his stake in Transocean and demanding a dividend.
CNBC's Scott Wapner offers insight on the personal issues between hedge fund manager Bill Ackman and Carl Icahn.
Hedge fund manager Bill Ackman and Carl Icahn appeared on CNBC in one of the most exciting television interchanges in history today. The best way to win big is to stay by the sidelines, says Mad Money host Jim Cramer.
The feud between Carl Icahn and hedge fund manager Bill Ackman goes back a decade ago, with CNBC's Scott Wapner.
James Paulsen, Wells Capital Management, explains why he sees the S&P 500 reaching as high as 1,700; and Joseph Tanious, JPMorgan Funds; Larry Glazer, Mayflower Advisors; and Jonathan Corpina, Meridian Equity Partners, weigh in.